Business Description
Galmed Pharmaceuticals Ltd
SIC : 2834
ISIN : IL0011313900
Description
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 239.59 | |||||
| Equity-to-Asset | 0.88 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 49.8 | |||||
| 3-Year EPS without NRI Growth Rate | 49.9 | |||||
| 3-Year FCF Growth Rate | 50.8 | |||||
| 3-Year Book Growth Rate | -55.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 64.97 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -10.69 | |||||
| 12-1 Month Momentum % | -50.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.48 | |||||
| Quick Ratio | 6.48 | |||||
| Cash Ratio | 6.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -52.5 | |||||
| Shareholder Yield % | 1.89 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -45.59 | |||||
| ROA % | -39.01 | |||||
| ROIC % | -177.97 | |||||
| 3-Year ROIIC % | 661.95 | |||||
| ROC (Joel Greenblatt) % | -3542.57 | |||||
| ROCE % | -48.37 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.18 | |||||
| Price-to-Tangible-Book | 0.18 | |||||
| EV-to-EBIT | 1.08 | |||||
| EV-to-EBITDA | 1.09 | |||||
| EV-to-FCF | 1.14 | |||||
| Price-to-Net-Current-Asset-Value | 0.24 | |||||
| Price-to-Net-Cash | 0.25 | |||||
| Earnings Yield (Greenblatt) % | 92.59 | |||||
| FCF Yield % | -100.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Galmed Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | 0 | ||
| Beta | 0 | ||
| Volatility % | 116.06 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0.370714 | ||
| 20-Day SMA (€) | 0 | ||
| 12-1 Month Momentum % | -50.18 | ||
| 52-Week Range (€) | 3.869999 - 12.524999 | ||
| Shares Outstanding (Mil) | 25.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Galmed Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Galmed Pharmaceuticals Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Galmed Pharmaceuticals Ltd Frequently Asked Questions
What is Galmed Pharmaceuticals Ltd(STU:GPH)'s stock price today?
The current price of STU:GPH is €4.86. The 52 week high of STU:GPH is €12.52 and 52 week low is €3.87.
When is next earnings date of Galmed Pharmaceuticals Ltd(STU:GPH)?
The next earnings date of Galmed Pharmaceuticals Ltd(STU:GPH) is 2024-11-14 Est..
Does Galmed Pharmaceuticals Ltd(STU:GPH) pay dividends? If so, how much?
Galmed Pharmaceuticals Ltd(STU:GPH) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers